JAMA Internal Medicine @JAMAInternalMed · 30 Aug 2026
Presented today at #ESCCongress from @JAMA_current: Meta-analysis: In #TransthyretinAmyloidCardiomyopathy, transthyretin gene silencers reduced all-cause mortality and recurrent cardiovascular events vs placebo. https://t.co/JguWrDPu7t https://t.co/fxvUu3C00J
1 359Views
0Likes
0Reposts
0Replies
0Quotes
1Bookmarks
Is that a lot?
0.91×vs this author's median1 493 views is typical
0Percentile for this authorof 5 recent posts
0.06×vs 100K–1M median21 891 views is typical
1.24%Reachviews ÷ followers
0.00%Engagement rateof viewers reacted